Molecular aspects of cannabinoid receptors

Critical Reviews in Neurobiology

Volumn 11, Issue 2-3, 1997, Pages 143-166

  Matsuda, Lisa A ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE   (United States)

Author keywords

Cannabis; G protein coupled receptor; Marijuana; 9 tetrahydrocannabinol

Indexed keywords

CALCIUM CHANNEL; CANNABINOID RECEPTOR; POTASSIUM CHANNEL; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ASSOCIATION CORTEX; AUTONOMIC NERVOUS SYSTEM; B LYMPHOCYTE; BLOOD CELL; CELL FUNCTION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GLIA CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LIGAND BINDING; LIMBIC CORTEX; MAST CELL; MOLECULAR BIOLOGY; MOLECULAR CLONING; MOTOR CORTEX; NERVE CELL; NERVE ENDING; NERVE FIBER; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; SPLEEN; THYMUS; TONSIL;

EID: 0030690545     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v11.i2-3.30     Document Type: Review

References (154)

1. Mechoulam, R., Cannabinoid chemistry, in Marijuana: Chemistry, Pharmacology, Metabolism and Cinical Effects, Mechoulam, R., Ed., Academic Press, New York, 1973.
2. Johnson, M. R. and Melvin, L. S., The discovery of nonclassical cannabinoid analgetics, in Cannabinoids as Therapeutic Agents, Mechoulam, R., Ed., CRC Press, Boca Raton, FL, 1986, 121.
3. D'Ambra, T. E., Estep, K. G., Bell, M. R.,Eissenstat, M. A., Josef, K. A., Ward, S. J., Haycock, D. A., Baizman, E. R., Casiano, F. M., Begun, N. C., Chippari, S. M., Grego, J. D., Kullnig, R. K., and Daley, G. T., Conformationally restrained analogues of Pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the cannabinoid receptor, J. Med. Chem., 35, 124, 1992.
4. Pacheco, M., Childers, S. R., Arnold, R., Casiano, F., and Ward, S. J., Aminoalkylindoles: actions on specific G-protein-linked receptors, J. Pharmacol. Exp. Ther., 257, 170, 1991.
5. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Brelier, J., and LeFur, G., SR141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Lett., 350, 240, 1994.
6. Pertwee, R., Griffin, G., Fernando, S., Li, X., Hill, A., and Makriyannis, A., AM630, a competitive cannabinoid receptor antagonist, Life Sci., 56, 1949, 1995.
7. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Alonso, R., Shire, D., Congy, C., Soubrie, P., Breliere, J. C. , and Le Fur, G., Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist, Life Sci., 56, 1941, 1995.
8. Tsou, K., Patrick, S. L., and Walker, J. M., Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist, Eur. J. Pharmacol., 280, R13, 1995.
9. Aceto, M. D., Scates, S. M., Lowe, J. A., and Martin, B. R., Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A, Eur. J. Pharmacol., 282, R1, 1995.
10. 9-tetrahydrocannabinol-induced responses and apparent agonist activity, J. Pharmacol. Exp. Ther., 277, 586, 1996.
11. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R., Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 1992.
12. Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., and Dixon, R. A. F., Structure and function of G protein-coupled receptors, Ann. Rev. Biochem., 63, 101, 1994.
13. Song, C. and Howlett, A. C., Rat brain cannabinoid receptors are N-linked glycosylated proteins, Life Sci., 56, 1983, 1995.
14. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I., Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 1990.
15. Munro, S., Thomas, K. L., and Abu-Shaar, M., Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365, 61, 1993.
16. Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., and Nakanishi, S., cDNA cloning of bovine substance-K receptor through oocyte expression system, Nature, 329, 836, 1987.
17. Parmentier, M., Libert, F., Maenhaut, C., Lefort, A., Gerard, C., Perret, J., Van Sande, J., Dumont, J. E., and Vassart, G., Molecular cloning of the thyrotropin receptor, Science, 246, 1620, 1989.
18. Libert, F., Parmentier, M., Lefort, A., Dinsart, C., Van Sande, J., Maenhaut, C., Simons, M., Dumont, J. E., and Vassart, G., Selective amplification and cloning of four new members of the G protein-coupled receptor family, Science, 244, 569, 1989.
19. Devane, W. A., Spain, J. W., Coscia, C. J., and Howlett, A. C., An assessment of the role of opioid receptors in the response to cannabimimetic drugs, J. Neurochem., 46, 1929, 1986.
20. Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., and Rice, K. C., Cannabinoid receptor localization on brain, Proc. Natl. Acad. Sci U.S.A., 87, 1932, 1990.
21. Gérard, C., Mollereau, C., Vassart, G., and Parmentier, M., Nucleotide sequence of a human cannabinoid receptor cDNA, Nucl. Acids Res., 18, 7142, 1990.
22. Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., Caput, D., and Ferrara, P., An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing, J. Biol. Chem., 270, 3726, 1995.
23. Slipetz, D. M., O'Neill, G. P., Favreau, L., Dufresne, C., Gallant, M., Gareau, Y., Guay, D., Labelle, M., and Metters, K. M., Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase, Mol. Pharmacol., 48, 352, 1995.
24. Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., and Mitchell, R. L., Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors, Mol. Pharmacol., 48, 443, 1995.
25. Savarese, T. M. and Fraser, C. M., In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors, Biochem. J., 283, 1, 1992.
26. Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., and Cone, R. D., The cloning of a family of genes that encode the melanocortin receptors, Science, 257, 1248, 1992.
27. Young, D., Waitches, G., Birchmeier, C., Fasano, O., and Wigler, M., Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains, Cell, 45, 711, 1986.
28. Hla, T. and Maciag, T., An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors, J Biol Chem., 265, 9308, 1990.
29. Eidne, K. A., Zabavnik, J., Peters, T., Yoshida, S., Anderson, L., and Taylor, P. L., Cloning, sequencing and tissue distribution of a candidate G protein-coupled receptor from rat pituitary gland, FEBS Lett., 292, 243, 1991.
30. Ross, P. C., Figler, R. A., Corjay, M. H., Barber, C. M., Adam, N., Harcus, D. R., and Lynch, K. R., RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution, Proc. Natl. Acad. Sci. U.S.A., 87, 3052, 1990.
31. Gérard, C. M., Mollereau, C., Vassart, G., and Parmentier, M., Molecular cloning of a human cannabinoid receptor which is also expressed in testis, Biochem. J., 279, 129, 1991.
32. Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., and Matsuda, L. A., Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones, Mol. Pharmacol., 42, 838, 1992.
33. Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., and Devane, W. A., Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction, Proc. Natl. Acad. Sci U.S.A., 90, 7656, 1993.
34. Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., and Mechoulam, R., Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase, J. Neurochem., 61, 352, 1993.
35. Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R., and Vogel, Z., The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling, FEBS Lett., 375, 143, 1995.
36. Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R., Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor, J. Neurosci., 15, 6552, 1995.
37. Song, Z. and Bonner, T. I., A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN 55212-2, Mol. Pharmacol., 49, 891, 1996.
38. 2+ channels in a neuronal expression system, Mol. Pharmacol., 49, 707, 1996.
39. Henry, D. J. and Chavkin, C., Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes, Neurosci. Lett., 186, 91, 1995.
40. Pettit, D. A. D., Showalter, V. M., Abood, M. E., and Cabrai, G. A., Expression of a cannabinoid receptor in baculovirus-infected insect cells, Biochem. Pharmacol., 48, 1231, 1994.
41. Devane, W. A., Dysarz, F. A. I., Johnson, M. R., Melvin, L. S., and Hewlett, A. C, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34, 605, 1988.
42. Compton, D. R., Rice, K. C., De Costa, B. R., Razdan, R. K., Melvin, L. S., Johnson, M. R., and Martin, B. R., Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities, J. Pharmacol. Exp. Ther., 265, 218, 1993.
43. Lu, R., Hubbard, J. R., Martin, B. R., and Kalimi, M. Y., Roles of sulfhydryl and disulphide groups in the binding of CP-55,940 to rat brain cannabinoid receptor, Mol. Cell. Biochem., 121, 119, 1993.
44. Kuster, J. E., Stevenson, J. I., Ward, S. J., D'Ambra, T. E., and Haycock, D. A., Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids, J. Pharmacol. Exp. Ther., 264, 1352, 1993.
45. 9-tetrahydrocannabinol treatment, Pharmacol. Biochem. Behav., 47, 33, 1994.
46. 9-tetrahydrocannabinol, Pharmacol. Biochem. Behav., 51, 731, 1995.
47. Hillard, C. J., Edgemond, W. S., and Campbell, W. B., Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide, J. Neurochem., 64, 677, 1995.
48. Belue, R. C., Howlett, A. C., Westlake, T. M., and Hutchings, D. E., The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats, Neurotoxicol. Teratol., 17, 25, 1995.
49. Das, S. K., Paria, B. C., Chakroborty, I., and Dey, S. K., Cannabinoid ligand-receptor signaling in the mouse uterus, Proc. Natl. Acad. Sci. U.S.A., 92, 4332, 1995.
50. Bouaboula, M., Bourrie, B., Rinaldi-Carmona, M., Shire, D., Le Fur, G., and Casellas, P., Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells, J. Biol. Chem., 270, 13973, 1995.
51. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., and Leon, A., Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide, Proc. Natl. Acad. Sci U.S.A., 92, 3376, 1995.
52. Shire, D., Calandra, B., Delpech, M., Dumont, X., Kaghad, M., Le Fur, G., Caput, D., and Ferrara, P., Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A, J. Biol. Chem., 271, 6941, 1996.
53. Mackie, K., Devane, W. A., and Hille, B., Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells, Mol. Pharmacol, 44, 498, 1993.
54. Birnbaumer, L., Abramowitz, J., and Brown, A. M., Receptor-effector coupling by G proteins, Biochim. Biophys. Acta, 1031, 163, 1990.
55. Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., deCosta, B. R., and Rice, K. C., Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci., 11, 563, 1991.
56. Houston, D. B. and Howlett, A. C., Solubilization of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins, Mol. Pharmacol., 43, 17, 1993.
57. 35S]thio]-triphosphate binding, Proc. Natl. Acad. Sci U.S.A., 92, 7242, 1995.
58. Howlett, A. C. and Fleming, R. M., Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma membranes, Mol. Pharmacol., 26, 532, 1984.
59. Howlett, A. C., Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes, Mol. Pharmacol., 27, 429, 1985.
60. Howlett, A. C., Cannabinoid inhibition of adenylate cyclase relative activity of constituents and metabolites of marihuana, Neuropharmacol., 26, 507, 1987.
61. i in the inhibition of adenylate cyclase by cannabimimetic drugs, Mol. Pharmacol., 29, 307, 1986.
62. Pacheco, M., Ward, S. J., and Childers, S. R., Identification of cannabinoid receptors in cultures of rat cerebellar granule cells, Brain Res., 603, 102, 1993.
63. Deadwyler, S. A., Hampson, R. E., Mu, J., Whyte, A., and Childers, S., Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process, J. Pharmacol. Exp. Ther., 273, 734, 1995.
64. Bidaut-Russell, M., Devane, W. A., and Howlett, A. C., Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain, J. Neurochem., 55, 21, 1990.
65. Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., and Kessler, F. K., Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism, Biochem. Pharmacol., 48, 1899, 1994.
66. Diaz, S., Specter, S., and Coffey, R. G., Suppression of lymphocyte adenosine 3′: 5′-cyclic monophosphate (cAMP) by delta-9-tetrahydrocannabinol, Int. J. Immunopharmacol., 15, 523, 1993.
67. Paria, B. C., Das, S. K., and Dey, S. K., The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling, Proc. Natl. Acad. Sci. U.S.A., 92, 9460, 1995.
68. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., and Bonner, T. I., The THC receptor and its implications, in Biological Basis of Substance Abuse, Korenman, S. G. and Barchas, J. D., Eds., Oxford University Press, Inc., New York, 1993, 95.
69. Childers, S. R., Sexton, T., and Roy, M. B., Effects of anandamide on cannabinoid receptors in rat brain membranes, Biochem. Pharmacol., 47, 711, 1994.
70. Deadwyler, S. A., Hampson, R. E., Bennett, B. A., Edwards, T. A., Mu, J., Pacheco, M. A., Ward, S. J., and Childers, S. R., Cannabinoids modulate potassium currents in cultured hippocampal neurons, Receptors and Channels, 1, 121, 1993.
71. Pacheco, M. A., Ward, S. J., and Childers, S. R., Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes, J. Neurochem., 62, 1773, 1994.
72. Caulfield, M. P. and Brown, D. A., Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a Pertussis toxin-sensitive mechanism, Br. J. Pharmacol., 106, 231, 1992.
73. Mackie, K. and Hille, B., Cannabinoid inhibit N-type calcium channels in neuroblastoma-glioma cells, Proc. Natl. Acad. Sci U.S.A., 89, 3825, 1992.
74. Hampson, R. E., Evans, G. J. O., Mu, J., Zhuang, S., King, V. C., Childers, S. R., and Deadwyler, S. A., Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons, Life Sci., 56, 2081, 1995.
75. 9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A, Biochem. Pharmacol., 51, 669, 1996.
76. Wartmann, M., Campbell, D., Subramanian, A., Burstein, S. H., and Davis, R. J., The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide, FEBS Lett., 359, 133, 1995.
77. Bouaboula, M., Poinot-Chazel, C., Bourrie, B., Canat, X., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., and Casellas, P., Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1, Biochem. J., 312, 637, 1995.
78. Turkanis, S. A., Karler, R., and Partlow, L. M., Differential effects of delta-9-tetrahydrocannabinol and its 11-hydroxy metabolite on sodium current in neuroblastoma cells, Brain Res, 560, 245, 1991.
79. Turkanis, S. A., Partlow, L. M., and Karler, R., Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells, Neuropharmacol, 30, 73, 1991.
80. Chang, M. C., Berkery, D., Laychock, S. G., and Schuel, H., Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marijuana, Biochem. Pharmacol., 42, 899, 1991.
81. Burstein, S., Budrow, J., Debatis, M., Hunter, S.A., and Subramanian, A., Phospholipase participation in cannabinoid-induced release of free arachidonic acid, Biochem. Pharmacol., 48, 1253, 1994.
82. Caenazzo, L., Hoehe, M. R., Hsieh, W.-T., Berrettini, W. H., Bonner, T. I., and Gershon, E. S., HindIII identifies a two allele DNA polymorphism of the human cannabinoid receptor gene (CNR), Nucl. Acids Res., 19, 4798, 1991.
83. Hoehe, M. R., Caenazzo, L., Martinez,M. M., Hsieh, W.-T., Modi, W. S., Gershon, E. S., and Bonner, T. L, Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15, New Biol., 3, 880, 1991.
84. Stubbs, L., Chittenden, L., Chakrabarti, A., and Onaivi, E., The gene encoding the central cannabinoid receptor is located in proximal mouse Chromosome 4, Mammalian Genome, 7, 165, 1996.
85. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P., Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur. J. Biochem., 232, 54, 1995.
86. Schwarz, H., Blanco, F. J., and Lotz, M., Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis, J. Neuroimmunol., 55, 107, 1994.
87. Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., and Schatz, A. R., Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation, Mol. Pharmacol., 42, 736, 1992.
88. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Deopech, B., Shire, D., Le Fur, G., and Casellas, P., Cannabinoid-receptor expression in human leukocytes, Eur. J. Biochem., 214, 173, 1993.
89. Daaka, Y., Friedman, H., and Klein, T. W., Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation, J. Pharmacol. Exp. Ther., 276, 776, 1996.
90. 9-Tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila, Proc. Soc. Exp. Biol. Med., 209, 205, 1995.
91. Lynn, A. B. and Herkenham, M., Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids, J. Pharmacol. Exp. Ther., 268, 1612, 1994.
92. Chang, M. C., Berkery, D., Schuel, R., Laychock, S. G., Zimmerman, A. M., Zimmerman, S., and Schuel, H., Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction, Mol. Reprod. Dev., 36, 507, 1993.
93. Cabral, G. A., Pettit, D. A. D., and Fischer-Stenger, K., Marijuana inhibition of cytotoxic T lymphocyte activity, in Advances in the Biosciences, Pergamon Press Ltd., 1993, 653.
94. Skaper, S.D., Buriani, A., Dal Toso, R., Petrelli, L., Romanello, S., Facci, L., and Leon, A., The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons, Proc. Natl. Acad. Sci. U.S.A., 93, 3984, 1996.
95. Mailleux, P., Parmentier, M., and Vanderhaeghen, J., Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides, Neurosci. Lett., 143, 200, 1992.
96. Matsuda, L. A., Bonner, T. I., and Lolait, S. J., Localization of cannabinoid receptor mRNA in rat brain, J. Comp. Neurol., 327, 535, 1993.
97. Mailleux, P. and Vanderhaeghen, J., Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry, Neurosci., 48, 655, 1992.
98. Jansen, E. M., Haycock, D. A., Ward, S. J., and Seybold, V. S., Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles, Brain Res., 575, 93, 1992.
99. 9-THC-DMH, J. Pharmacol. Exp. Ther., 263, 1383, 1992.
100. Mailleux, P. and Vanderhaeghen, J. J., Localization of cannabinoid receptor in the human developing and adult brain. Higher levels in the striatonigral neurons, Neurosci. Lett., 148, 173, 1992.
101. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors, Brain Res., 544, 145, 1991.
102. Compton, D. R., Johnson, M. R., Melvin, L. S., and Martin, B. R., Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents, J. Pharmacol. Exp. Ther., 260, 201, 1992.
103. Smith, P. B., Compton, D. R., Welch, S. P., Razdan, R. J., Mechoulam, R., and Martin, B. R., The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice, J. Pharmacol. Exp. Ther., 270, 219, 1994.
104. Herkenham, M., Lynn, A. B., deCosta, B. R., and Richfield, E. K., Neuronal localization of cannabinoid receptors in the basal ganglia of the rat, Brain Res., 547, 267, 1991.
105. Glass, M., Faull, R. L. M., and Dragunow, M., Loss of cannabinoid receptors in the substantia nigra in Huntington's disease, Neurosci., 56, 523, 1993.
106. Richfield, E. K. and Herkenham, M., Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus, Ann. Neurol., 36, 577, 1994.
107. Hamburgh, M., Observations on the neuropathology of 'reeler,' a neurological mutation in mice, Experientia, 16, 460, 1960.
108. Rakic, P. and Sidman, R. L., Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice, J. Comp. Neurol., 152, 103, 1973.
109. Landis, D. M. D. and Sidman, R. L., Electron microscopic analysis of postnatal histogenesis in the cerebellar cortex of staggerer mutant mice, J. Comp. Neurol., 179, 831, 1978.
110. Herkenham, M., Groen, B. G. S., Lynn, A. B., deCosta, B. R., and Richfield, E. K., Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum, Brain Res., 552, 301, 1991.
111. McLaughlin, C. R. and Abood, M. E., Developmental expression of cannabinoid receptor mRNA, Dev. Brain Res., 76, 75, 1993.
112. Herkenham, M., Fox, R. J., Lynn, A. B., Lolait, S. J., and Matsuda, L. A., Development of cannabinoid receptor binding and gene expression in the rat (Neurobehav. Teratol. Soc. Abst.), Teratology, 43, 486, 1991.
113. de Fonseca, F. R., Ramos, J. A., Bonnin, A. , and Fernandez-Ruiz, J. J., Presence of cannabinoid binding sites in the brain from early postnatal ages, NeuroReport, 4, 135, 1993.
114. Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A., and Herkenham, M., Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains, Neurosci., 63, 637, 1994.
115. Mailleux, P. and Vanderhaeghen, J., Age-related loss of cannabinoid receptor binding sites and mRNA in the rat striatum, Neurosci Lett., 147, 179, 1992.
116. Mailleux, P. and Vanderhaeghen, J., Glucocorticoid regulation of cannabinoid receptor messenger RNA levels in the rat caudate-putamen. An in situ hybridization study, Neurosci Lett., 156, 51, 1993.
117. Mailleux, P. and Vanderhaeghen, J., Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study, J. Neurochem., 61, 1705, 1993.
118. Mailleux, P. and Vanderhaeghen, J., Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen, Eur. J. Pharmacol., 266, 193, 1994.
119. Dill, J. A. and Howlett, A. C., Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs, J. Pharmacol. Exp. Ther., 244, 1157, 1988.
120. Oviedo, A., Glowa, J., and Herkenham, M., Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study, Brain Res., 616, 293, 1993.
121. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain, Pharmacol. Biochem. Behav., 46, 575, 1993.
122. Specter, S., Diaz, S., and Liu, C., Cannabinoid stimulation of arachidonate metabolism in human peripheral blood mononuclear leukocytes, in The Brain Immune Axis and Substance Abuse, Sharp, B., Ed., Plenum Press, New York, 1995, 97.
123. Derocq, J., Segui, M., Marchand, J., Le Fur, G., and Casellas, P., Cannabinoids enhance human B-cell growth at low nanomolar concentrations, FEBS Lett., 369, 177, 1995.
124. Watzl, B., Scuderi, P., and Watson, R. R., Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro, Int. J. Immunopharmacol., 13, 1091, 1991.
125. 9-Tetrahydrocannabinol selectively inhibits macrophage costimulatory activity and down-regulates heatstable antigen expression, J. Pharmacol. Exp. Ther., 277, 1315, 1996.
126. Cabrai, G. A. and Vasquez, R., Marijuana decreases macrophage antiviral and antitumor activities, Adv. Biosci., 80, 93, 1991.
127. 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes, Cell. Immunol., 154, 99, 1994.
128. 9-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase, J. Biol. Chem., 271, 9902, 1996.
129. Titishov, N., Mechoulam, R., and Zimmerman, A. M., Stereospecific effects of (-)- and (+)-7-hydroxy-delta-6-tetrahydrocannabinol-dimethylheptyl on the immune system in mice, Pharmacology, 39, 337, 1989.
130. Martin, B. R., Compton, D. R., Thomas, B. F., Prescott, W. R., Little, P. J., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R., and Ward, S. J., Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs, Pharmacol. Biochem. Behav., 40, 471, 1991.
131. Nah, S., Saya, D., and Vogel, Z., Cannabinoids inhibit agonist-stimulated formation of inositol phosphates in rat hippocampal cultures, Eur. J. Pharmacol., 246, 19, 1993.
132. Edsall, S. A., Knapp, R. J., Vanderah, T. W., Roeske, W. R., Consroe, P., and Yamamura, H. I., Antisense oligodeoxynucleotide treatment to the brain cannabinoid receptor inhibits antinociception, NeuroReport, 7, 593, 1996.
133. Mailleux, P., Verslype, M., Preud'homme, X., and Vanderhaeghen, J., Activation of multiple transcription factor genes by tetrahydrocannabinol in rat fore-brain, NeuroReport, 5, 1265, 1994.
134. Glass, M. and Dragunow, M., Induction of the krox-24 transcription factor in striosomes by a cannabinoid agonist, NeuroReport, 6, 241, 1995.
135. Mailleux, P. and Vanderhaeghen, J., δ-9-Tetrahydrocannabinol regulates substance P and enkephalin mRNA levels in the caudate-putamen, Eur. J. Mol. Pharmacol., 267, R1, 1994.
136. 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study, Brain Res., 451, 59, 1988.
137. 9-Tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex, Eur. J. Pharmacol., 190, 259, 1990.
138. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of pre-synaptic basal dopamine efflux in nucleus accum-bens of conscious, freely moving rats as measured by intracerebral microdialysis, Psychopharmacol., 102, 156, 1990.
139. Xue, B. G., Belluzzi, J. D., and Stein, L., In vitro reinforcement of hippocampal bursting by the cannabinoid receptor agonist (-)-CP-55,940, Brain Res., 626, 272, 1993.
140. Gifford, A. N. and Ashby; C. R., Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist WIN 55212-2 and is potentiated by the cannabinoid antagonist SR 141716A, J. Pharmacol. Exp. Ther., 277, 1431, 1996.
141. Miller, A. S. and Walker, J. M., Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata, Eur. J. Pharmacol., 279, 179, 1995.
142. Kirby, M. T., Hampson, R. E., and Deadwyler, S. A., Cannabinoids selectively decrease paired-pulse facilitation of perforant path synaptic potentials in the dentate gyrus in vitro, Brain Res., 688, 114, 1995.
143. Collin, C., Devane, W.A., Dahl, D., Lee, C., Axelrod, J., and Alkon, D. L., Long-term synaptic transformation of hippocampal CA1 γ-aminobutyric acid synapses and the effect of anandamide, Proc. Natl. Acad. Sci U.S.A., 92, 10167, 1995.
144. Venance, L., Piomelli, D., Glowinski, J., and Giaume, C., Inhibition by anandamide of gap Junctions and intercellular calcium signalling in striatal astrocytes, Nature, 376, 590, 1995.
145. Schuel, H., Goldstein, E., Mechoulam, R., Ziminerman, A. M., and Zimmerman, S., Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction, Proc. Natl. Acad. Sci. U.S.A., 91, 7678, 1994.
146. Schuel, H., Berkery, D., Schuel, R., Chang, M. C., Zimmerman, A. M., and Zimmerman, S., Reduction of the fertilizing capacity of sea urchin sperm by cannabinoids derived from marihuana. I. Inhibition of the acrosome reaction induced by egg jelly, Mol. Reprod. Dev., 29, 51, 1991.
147. Hanus, L., Gopher, A., Almog, S., and Mechoulam, R., Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor, J. Med. Chem., 36, 3032, 1993.
148. Priller, J., Briley, E. M., Mansouri, J., Devane, W. A., Mackie, K., and Felder, C. C., Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors, Mol. Pharmacol., 48, 288, 1995.
149. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z., Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem. Pharmacol, 50, 83, 1995.
150. Mechoulam, R., McCallum, N. K., and Burstein, S., Recent advances in the chemistry and biochemistry of cannabis, Chem. Rev., 76, 75, 1976.
151. Burstein, S. H., Audette, C. A., Charalambous, A., Doyle, S. A., Guo, Y., Hunter, S. A., and Makriyannis, A., Detection of cannabinoid receptors by photoaffinity labelling, Biochem. Biophys. Res. Comm., 176, 492, 1991.
152. Devane, W. A., Breuer, A., Sheskin, T., Järbe, T. U. C., Eisen, M. S., and Mechoulam, R., A novel probe for the cannabinoid receptor, J. Med. Chem., 35, 2065, 1992.
153. Charalambous, A., Yan, G., Houston, D. B., Hewlett, A. C., Compton, D. R., Martin, B. R., and Makriyannis, A., 5′-Azido-Δ8-THC: a novel photoaffinity label for the cannabinoid receptor, J. Med. Chem., 35, 3076, 1992.
154. Guo, Y., Abadji, V., Morse, K. L., Fournier, D. J., Li, X., and Makriyannis, A., (-)-11-Hydroxy-7′-isothiocyanato-1′,1′-dimethyl heptyl-Δ8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain, J. Med. Chem., 37, 3867, 1994.